InnoCan Pharma Corporation
InnoCan Pharma Corporation
CSE Index:
CSE CompositeCurrency:
CAD The Corporation's business can be described as three distinct operating segments relating to the incorporation in products of CBD in their formulation: (i) research, development, marketing, distribution and sales of InnoCan-branded OTC pharmaceutical products; (ii) research and development of non-pharmaceutical products for third parties in exchange for fees and/or royalties; and (iii) research and development of hydrogels containing liposomes intended for licensing or sale to third party pharmaceutical corporations for manufacturing, distribution and sales.
InnoCan Pharma Corporation (INNO)
0.195
0.00 (0.00%)
InnoCan Pharma Corporation (INNO)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Bid Size
1,500
Bid Price
0.195
Ask Price
0.195
Ask Size
4,500
Volume
1,500
Last Price
0.195
Tick
Net Change
Prev Close
0.195
Open
0.195
Day High
0.195
Day Low
0.195
52 Week High
0.33
52 Week Low
0.16
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
0
Bid Price
0.00
Ask Price
0.00
Ask Size
0
Volume
0
Last Price
Tick
Net Change
Prev Close
Open
0.00
Day High
0.00
Day Low
0.00
52 Week High
52 Week Low
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
1,500
Bid Price
0.195
Ask Price
0.195
Ask Size
4,500
Volume
1,500
Last Price
0.195
Tick
Net Change
Prev Close
0.195
Open
0.195
Day High
0.195
Day Low
0.195
52 Week High
0.33
52 Week Low
0.16
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
0
Bid Price
0.00
Ask Price
0.00
Ask Size
0
Volume
0
Last Price
Tick
Net Change
Prev Close
Open
0.00
Day High
0.00
Day Low
0.00
52 Week High
52 Week Low
*Note: Bid Size and Ask Size fields are displayed as actual quantities
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| GenerationIACP | 1,000 | 0.195 | 0.195 | 4,500 | RBC Capital Markets |
| GenerationIACP | 500 | 0.195 | 0.205 | 20,000 | Anonymous |
| GenerationIACP | 1,000 | 0.19 | 0.21 | 85,000 | Canaccord Capital Corporation |
| GenerationIACP | 1,000 | 0.18 | 0.21 | 42,000 | Canaccord Capital Corporation |
| GenerationIACP | 1,000 | 0.17 | 0.21 | 45,000 | Canaccord Capital Corporation |
| Anonymous | 1,000 | 0.16 | 0.21 | 36,500 | Canaccord Capital Corporation |
| GenerationIACP | 1,000 | 0.15 | 0.23 | 37,000 | Canaccord Capital Corporation |
| TD Securities Inc. | 500 | 0.14 | 0.23 | 45,000 | Canaccord Capital Corporation |
| Anonymous | 2,000 | 0.135 | 0.24 | 40,000 | Canaccord Capital Corporation |
| Anonymous | 5,000 | 0.125 | 0.25 | 40,000 | Canaccord Capital Corporation |
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 2 | 1,500 | 0.195 | 0.195 | 4,500 | 1 |
| 1 | 1,000 | 0.19 | 0.205 | 20,000 | 1 |
| 1 | 1,000 | 0.18 | 0.21 | 208,500 | 4 |
| 1 | 1,000 | 0.17 | 0.23 | 82,000 | 2 |
| 1 | 1,000 | 0.16 | 0.24 | 40,000 | 1 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| Date/Time | Price | Change | Volume | Buyer | Seller | Venue |
|---|---|---|---|---|---|---|
| Apr 2, 13:30 | 0.195 | 0.00 | 500 | GenerationIACP | RBC Capital Markets | CSE |
| Apr 2, 13:30 | 0.195 | 0.00 | 1,000 | GenerationIACP | RBC Capital Markets | CSE |
| Apr 1, 19:12 | 0.195 | 0.00 | 500 | Anonymous | RBC Capital Markets | CSE |
| Apr 1, 19:12 | 0.195 | 0.00 | 1,000 | Anonymous | RBC Capital Markets | CSE |
| Apr 1, 15:25 | 0.195 | 0.00 | 1,000 | GenerationIACP | RBC Capital Markets | CSE |
Company Info
Address
1015, 926 - 5 Avenue SW
Calgary, AB T2P 0N7
CanadaPhone
403-777-1519Email
irisb@innocanpharma.comWebsite
http://innocanpharma.comListing date
Tuesday, September 24, 2019Transfer Agent
Odyssey Trust CompanySEDAR Information
Filing Type
Any
News Releases
Material Change Report
Management's Discussion & Analysis
Financial Statements
Timeframe
1 week1 month3 month6 month1 yearAll Time
InnoCan Pharma Corporation
Date:
Jan 8, 2025
InnoCan Pharma Corporation
Date:
Nov 20, 2024
InnoCan Pharma Corporation
Date:
Nov 20, 2024
InnoCan Pharma Corporation
Date:
Sep 3, 2024
InnoCan Pharma Corporation
Date:
Aug 12, 2024
InnoCan Pharma Corporation
Date:
Aug 12, 2024
InnoCan Pharma Corporation
Date:
May 27, 2024
InnoCan Pharma Corporation
Date:
May 27, 2024
InnoCan Pharma Corporation
Date:
Apr 1, 2024
InnoCan Pharma Corporation
Date:
Apr 1, 2024
InnoCan Pharma Corporation
Date:
Apr 1, 2024
InnoCan Pharma Corporation
Date:
Apr 1, 2024
InnoCan Pharma Corporation
Date:
Mar 25, 2024
InnoCan Pharma Corporation
Date:
Nov 29, 2023
InnoCan Pharma Corporation
Date:
Nov 29, 2023
InnoCan Pharma Corporation
Date:
Oct 23, 2023
InnoCan Pharma Corporation
Date:
Aug 24, 2023
InnoCan Pharma Corporation
Date:
Aug 24, 2023
InnoCan Pharma Corporation
Date:
Aug 11, 2023
InnoCan Pharma Corporation
Date:
May 30, 2023
InnoCan Pharma Corporation
Date:
May 30, 2023
InnoCan Pharma Corporation
Date:
Mar 30, 2023
InnoCan Pharma Corporation
Date:
Mar 30, 2023
InnoCan Pharma Corporation
Date:
Mar 30, 2023
InnoCan Pharma Corporation
Date:
Mar 30, 2023
InnoCan Pharma Corporation
Date:
Feb 22, 2023
InnoCan Pharma Corporation
Date:
Nov 28, 2022
InnoCan Pharma Corporation
Date:
Nov 28, 2022
InnoCan Pharma Corporation
Date:
Aug 29, 2022
InnoCan Pharma Corporation
Date:
Aug 29, 2022
InnoCan Pharma Corporation
Date:
May 30, 2022
InnoCan Pharma Corporation
Date:
May 30, 2022
InnoCan Pharma Corporation
Date:
May 16, 2022
InnoCan Pharma Corporation
Date:
May 16, 2022
InnoCan Pharma Corporation
Date:
May 16, 2022
InnoCan Pharma Corporation
Date:
May 16, 2022
InnoCan Pharma Corporation
Date:
May 16, 2022
InnoCan Pharma Corporation
Date:
May 16, 2022
InnoCan Pharma Corporation
Date:
Apr 13, 2022
InnoCan Pharma Corporation
Date:
Apr 13, 2022
InnoCan Pharma Corporation
Date:
Mar 31, 2022
InnoCan Pharma Corporation
Date:
Mar 31, 2022
InnoCan Pharma Corporation
Date:
Nov 29, 2021
InnoCan Pharma Corporation
Date:
Nov 29, 2021
InnoCan Pharma Corporation
Date:
Oct 22, 2021
InnoCan Pharma Corporation
Date:
Aug 30, 2021
InnoCan Pharma Corporation
Date:
Aug 30, 2021
InnoCan Pharma Corporation
Date:
May 31, 2021
InnoCan Pharma Corporation
Date:
May 31, 2021
InnoCan Pharma Corporation
Date:
Mar 31, 2021
InnoCan Pharma Corporation
Date:
Mar 31, 2021
InnoCan Pharma Corporation
Date:
Jan 8, 2021
InnoCan Pharma Corporation
Date:
Nov 30, 2020
InnoCan Pharma Corporation
Date:
Nov 30, 2020
InnoCan Pharma Corporation
Date:
Aug 31, 2020
InnoCan Pharma Corporation
Date:
Aug 31, 2020
InnoCan Pharma Corporation
Date:
Jun 4, 2020
InnoCan Pharma Corporation
Date:
Jun 4, 2020
InnoCan Pharma Corporation
Date:
Jun 4, 2020
InnoCan Pharma Corporation
Date:
Jun 4, 2020
InnoCan Pharma Corporation
Date:
Jun 4, 2020
InnoCan Pharma Corporation
Date:
Jun 4, 2020
InnoCan Pharma Corporation
Date:
Jun 4, 2020
InnoCan Pharma Corporation
Date:
Apr 8, 2020
InnoCan Pharma Corporation
Date:
Apr 8, 2020
InnoCan Pharma Corporation
Date:
Nov 29, 2019
InnoCan Pharma Corporation
Date:
Nov 29, 2019
InnoCan Pharma Corporation
Date:
Oct 8, 2019
InnoCan Pharma Corporation
Date:
Sep 13, 2019
InnoCan Pharma Corporation
Date:
Aug 29, 2019
InnoCan Pharma Corporation
Date:
May 31, 2019
InnoCan Pharma Corporation
Date:
May 31, 2019
Company Info
Address
1015, 926 - 5 Avenue SW
Calgary, AB T2P 0N7
CanadaPhone
403-777-1519Email
irisb@innocanpharma.comWebsite
http://innocanpharma.comListing date
Tuesday, September 24, 2019Transfer Agent
Odyssey Trust CompanyCapitalization
Issued & Outstanding:
286938271Reserved for Issuance:
24346374Bulletins
24/09/2019
2019-0927 – New Listing - InnoCan Pharma Corporation (INNO)
le 24 septembre/September 2019
The common shares of InnoCan Pharma Corporation have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
